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Abstract
Background: Red pitaya (Hylocereus polyrhizus) or known as buah naga merah in Malay belongs to the cactus
family, Cactaceae. Red pitaya has been shown to give protection against liver damage and may reduce the stiffness
of the heart. Besides, the beneficial effects of red pitaya against obesity have been reported; however, the
mechanism of this protection is not clear. Therefore, in the present study, we have investigated the red pitaya-
targeted genes in obesity using high-carbohydrate, high-fat diet-induced metabolic syndrome rat model.
Methods: A total of four groups were tested: corn-starch (CS), corn-starch + red pitaya juice (CRP), high-carbohydrate,
high-fat (HCHF) and high-carbohydrate, high-fat + red pitaya juice (HRP). The intervention with 5 % red pitaya juice was
continued for 8 weeks after 8 weeks initiation of the diet. Retroperitoneal, epididymal and omental fat pads were
collected and weighed. Plasma concentration of IL-6 and TNF-α were measured using commercial kits. Gene
expression analysis was conducted using RNA extracted from liver samples. A total of eighty-four genes related to
obesity were analyzed using PCR array.
Results: The rats fed HCHF-diet for 16 weeks increased body weight, developed excess abdominal fat deposition and
down-regulated the expression level of IL-1α, IL-1r1, and Cntfr as compared to the control group. Supplementation of
red pitaya juice for 8 weeks increased omental and epididymal fat but no change in retroperitoneal fat was observed.
Red pitaya juice reversed the changes in energy balance homeostasis in liver tissues by regulation of the expression
levels of Pomc and Insr. The increased protein expression levels of IL-6 and TNF-α in HCHF group and red pitaya
treated rats confirmed the results of gene expression.
Conclusion: Collectively, this study revealed the usefulness of this diet-induced rat model and the beneficial effects of red
pitaya on energy balance homeostasis by modulating the anorectic, orexigenic and energy expenditure related genes.
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Background
The increasing incidence of obesity worldwide could result
from complex interactions between environmental, genetic
[1] and psychosocial factors [2]. The social-environmental
influences such as reduced physical activity, increased sed-
entary behavior and increased accessibility of high-fat and
energy-dense foods facilitate the obesity pandemic by dis-
rupting the body’s energy balance. Energy balance is defined
as the difference between energy intake and energy expend-
iture including basal metabolism, physical activity and
adaptive thermogenesis [2]. A state of positive energy bal-
ance will occur when energy intake exceeds energy expend-
iture, leading to increased storage of energy as adipose
tissue. Genetic factors may also influence body weight by
affecting one or more component (s) of energy balance [3].
The physiological control system for energy intake and
body weight is complex and involves extensive changes of
gene expression throughout the body. It is postulated that
the central nervous system controls energy balance
through several mechanisms. These include it influence
on feeding and physical activity behavior, the regulation of
the autonomic nervous system activities including metab-
olism, and changes in key hormones such as leptin,
ghrelin, insulin, growth hormone, sex steroids, cortisol
and thyroid hormones [1, 4–6]. Therefore, it is critical to
understand the gut-brain interaction underlying the appe-
tite and feeding regulation of energy balance to develop
new pharmacogenetical strategy for obesity studies.
Red pitaya is a cactus fruit originating from Mexico. In
Malaysia, this fruit is known as red dragon fruit or ‘buah
naga merah’, possibly due to the scaly structure of the
peel. The beneficial effects of red pitaya reported in la-
boratory animal studies could be due to its ability to in-
crease antioxidant capacity and suppress oxidative stress
damage [7–9]. Our previous study indicated that red
pitaya supplementation ameliorated liver and cardiovas-
cular damage induced by high-carbohydrate, high-fat
feeding [10]. However, the effects of red pitaya supple-
mentation on obesity along with its related mechanism
not clear. Red pitaya supplementation increases energy
intake without increasing body weight [10], so it is hy-
pothesized that red pitaya may stimulate anorectic genes
or down-regulate orexigenic genes to increase energy ex-
penditure. Therefore, the present work determined the
changes in anorectic and orexigenic genes as well as the
inflammatory pathway in a rat model of diet-induced
obesity following supplementation with red pitaya.
Methods
Preparation of diet
Red pitaya was obtained from Queensland Australia. The
identification of the fruit has been done by a botanist from
Biodiversity Unit, Institute of Biosciences, Universiti Putra
Malaysia. The voucher number is SK-2440/14. The fruits
were then cleaned, and the fruit pulp was squeezed using
juice maker. Sample preparation was conducted in re-
duced light condition in order to minimize the pigment
loss [10].
Animals and diet
The experimental protocols have been described in our
previous publication [10]. In brief, the experimental groups
consisted of 48 male Wistar rats (aged 8–9 weeks; weight
337 ± 5 g) supplied by and individually housed at The
University of Southern Queensland animal house. All ex-
perimental groups were housed in a temperature-
controlled, 12 hour light–dark cycle environment with ad
libitum access to water and the group specific diet. Daily
body weight, feed and water measurements were taken to
monitor the day-to-day health of the rats and the results
have been reported in our previous publication [10]. The
rats were randomly divided into four groups based on their
diet: corn starch (CS; n = 12); corn starch + red pitaya juice
(CRP; 5 % in the diet; n = 12); high-carbohydrate, high-fat
(HCHF; n = 12); High-carbohydrate, high-fat + red pitaya
juice (HRP; n = 12). Fructose (25 %) was added as drinking
water for all high-carbohydrate, high-fat fed rats, while corn
starch group was given normal water. The detailed macro-
and micro-nutrient composition of the CS and HCHF diets
are reported in previous publications [11, 12]. Red pitaya
juice was administered for 8 weeks starting from 8 weeks
after the initiation of the CS or HCHF diet. All the experi-
mental protocols were approved by the Animal Experimen-
tation Ethics Committee of The University of Southern
Queensland under the guidelines of the National Health
and Medical Research Council of Australia.
Organ weights
Terminal anaesthesia was induced via intraperitoneal in-
jection of pentobarbitone sodium (Lethabarb, 100 mg/kg).
Heparin (Sigma-Aldrich Australia) was administered
(100 IU) through the right femoral vein and blood (about
5 ml) was taken from the abdominal aorta. Immediately
after the rats were killed, the abdominal fat mass as the
retroperitoneal, epididymal and omental fat pads were col-
lected. The organ weights were normalized to the tibial
length at the time of their removal (in mg/mm).
Visceral adiposity index
Visceral adiposity index (%) was calculated as: ([retroperi-
toneal fat (g) + omental fat (g) + epididymal fat (g)]/[body
weight (g)]) × 100 and expressed as adiposity percent [12].
Inflammatory markers
Plasma concentrations of interleukin 6 (IL-6) and TNF-
alpha were quantified based on manufacturer’s guidelines
using commercially available ELISA kits. Plasma C-
reactive protein (CRP) was estimated using a commercial
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kit according to the manufacturer-provided standards and
protocol using a Roche/Hitachi cobas c system.
Isolation of total RNA
During terminal experiments, liver samples were collected
and immediately stored at −80 °C freezer. Total RNA from
corn starch (CS), corn starch + red pitaya (CRP), high-
carbohydrate, high-fat (HCHF) and high-carbohydrate,
high-fat + red pitaya (HRP) groups was isolated from liver
samples using RNeasy® plus mini kit (Qiagen, Valencia, CA)
according to manufacturer’s protocol. Three replicates were
analyzed for each group (CS, CRP, HCHF and HRP). Basic-
ally, 25 mg liver samples were excised and immediately ho-
mogenized in Buffer RLT plus. The genomic DNA was
removed and purified from the lysate liver sample. Finally,
the RNeasy spin column was placed into a new 2 mL col-
lection tube and centrifuged at 12000 rpm for 1 minute.
The 2 mL collection tube was then discarded. The RNA
bound at the RNeasy spin column was eluted in a new
1.5 mL collection tube with 40 μL RNase-free water and
centrifuged at 12000 rpm for 1 minute. The concentration
of extracted RNA from the samples was determined by
measuring at 260 nm using a Nano-Drop 1000 Spectropho-
tometer (Thermo Scientific, Waltham, MA). In brief, 1 μL
of RNase-free water was added to pedestal for blank sam-
ple. Then, 1 μL of RNA sample was added. The integrity of
extracted RNA sample was measured using Bioanalyzer
(Agilent’s RNA 6000 Nano kit).
cDNA synthesis for real-time Reverse Transcription- (RT) PCR
cDNA was prepared using RT2 profiler PCR array first
strand kit based on manufacturer’s instructions. Briefly,
genomic DNA elimination mix was prepared by mixing
RNA (volume varies based on the concentration ob-
tained), 2 μL of gDNA elimination buffer and RNase-
free water to form a total volume of 10 μL. The mixture
was mixed by gently pipetting and the genomic DNA
elimination mix was then incubated for 5 minutes at
42 °C. It was immediately placed on ice for at least 1 mi-
nute. The reverse-transcription mix was prepared ac-
cording to manufacturer’s guidelines. Ten μL of reverse-
transcription mix was added to tube containing 10 μL
genomic DNA elimination mix, and incubated at 42 °C
for exactly 15 minutes. The reaction was stopped by in-
cubating at 95 °C for 5 minutes to inactivate the reverse
transcriptase. The 20 μL of cDNA synthesis reaction
mixture was mixed with 91 μL of RNase-free water mak-
ing a total 111 μL of reaction mixture. The reaction mix-
ture was placed on ice until further use.
Array-based SYBR® Green RT-PCR
The constitutive gene expression profiling was conducted
using to RT2 profiler PCR array related to obesity signal
transduction according to manufacturer’s protocols. The
gene array profiled the expression of 84 genes including
orexigenic genes, anorectic genes, and related to energy ex-
penditure (Table 1, PARN-017Z-12, RT2 Profiler™ PCR
Array Rat Obesity). The array included the controls for hu-
man genomic DNA contamination, reverse-transcription,
positive PCR control, and 5 housekeeping genes to
normalize the relative gene expression for analysis of data.
The five housekeeping genes were ribosomal protein large
P1 (Rp1p1), hypoxanthine phosphoribosyltransferase 1
(Hprt1), ribosomal protein L13A (Rp113a), lactate dehydro-
genase A (Ldha), and β-actin (Actb). The PCR components
mix were prepared with 1150 μL of 2 x RT2 SYBR Green
ROX FAST mastermix, 102 μL of cDNA synthesis reaction,
and 1048 μL of RNase-free water combined making a total
volume of 2300 μL. Then, the RT2 profiler PCR array was
removed from its sealed bag, and the array was slid into the
Rotor-Disc 100 Loading Block using the tab position A1
and the tube guide holes. Twenty μL of PCR component
mix was pipetted into each well of the RT2 profiler PCR
array. For each sample, the RT2 profiler PCR array was con-
ducted in triplicate.
Real time PCR was performed using a two-step cycling
program on rotor gene real time PCR machine (Qiagen,
Valencia, CA): 10 min at 95 °C (cycle 1) followed by
40 cycles of 15 s at 95 °C and 1 min at 60 °C. SYBR
green fluorescence was detected and recorded. The
threshold cycle (CT) above the background for each re-
action was then calculated.
Statistical analysis
Data for organ weights, and inflammatory markers were
analyzed using GraphPad Prism version 5.00 for
Windows (San Diego, CA, USA). All data were pre-
sented as mean ± SEM. All group data were tested for
variance using Bartlett’s test. Variables that were not
normally distributed were transformed (using log 10
function) prior to statistical analysis. The effects of diet,
treatment and their interactions were tested by two-way
analysis of variance. When interaction and/or the main
effects were significant, means were compared using
Newman-Keuls multiple-comparison post hoc test. A
nonparametric test, the Kruskal-Wallis test, was
performed when transformations did not result in nor-
mality or constant variance. The gene expression data
was analyzed using RT2 Profiler PCR Array Data analysis
version 3.5 from SABiosciences website. All data were
normalized by one housekeeping gene (endogenous con-
trol). The fold change among the groups were obtained
from ΔΔCT. ΔCT was defined as the value of subtract-
ing the CT value of endogenous control from the CT
value of the target messenger RNA (mRNA). Student’s t-
test was used to determine the differences in gene
expression. The significant values were considered at the
level of p < 0.05.
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Table 1 The symbol and description of genes in the PCR array
Position Symbol Description Gene Name
A01 Adcyap1 Adenylate cyclase activating polypeptide 1 Pacap
A02 Adcyap1r1 Adenylate cyclase activating polypeptide 1 receptor 1 PACAP-R1A, PACAPR1, PACAPR1A
A03 Adipoq Adiponectin, C1Q and collagen domain containing Acdc, Acrp30
A04 Adipor1 Adiponectin receptor 1 –
A05 Adipor2 Adiponectin receptor 2 –
A06 Adra2b Adrenergic, alpha-2B-, receptor –
A07 Adrb1 Adrenergic, beta-1-, receptor B1AR,RATB1AR
A08 Agrp Agouti related protein homolog (mouse) –
A09 Apoa4 Apolipoprotein A-IV Apo-AIV, ApoA IV, apoAIV
A10 Atrn Attractin –
A11 Bdnf Brain-derived neurotrophic factor MGC105254
A12 Brs3 Bombesin-like receptor 3 –
B01 C3 Complement component 3 –
B02 Calca Calcitonin-related polypeptide alpha CAL6, CGRP, Cal1, Calc, RATCAL6, calcitonin
B03 Calcr Calcitonin receptor –
B04 Cartpt CART prepropeptide Cart
B05 Cck Cholecystokinin –
B06 Cckar Cholecystokinin A receptor Cck-ar
B07 Clps Colipase, pancreatic COLQ
B08 Cnr1 Cannabinoid receptor 1 (brain) SKR6R
B09 Cntf Ciliary neurotrophic factor –
B10 Cntfr Ciliary neurotrophic factor receptor –
B11 Crh Corticotropin releasing hormone CRF
B12 Crhr1 Corticotropin releasing hormone receptor 1 –
C01 Drd1a Dopamine receptor D1A D1a, Drd-1, Drd1
C02 Drd2 Dopamine receptor D2 –
C03 Gal Galanin prepropeptide Galn
C04 Galr1 Galanin receptor 1 Galnr1
C05 Gcg Glucagon GLP-1
C06 Gcgr Glucagon receptor MGC93090
C07 Gh1 Growth hormone 1 Gh,RNGHGP
C08 Ghr Growth hormone receptor GHR, BP, MGC12496, MGC156665
C09 Ghrl Ghrelin/obestatin prepropeptide –
C10 Ghsr Growth hormone secretagogue receptor –
C11 Glp1r Glucagon-like peptide 1 receptor Glip, RATGL1RCP
C12 Grp Prolactin releasing hormone receptor Gpr10, Uhr-1
D01 Grpr Melanin-concentrating hormone receptor 1 Gpr24, Mch-1r, Slc1
D02 HcRt Hypocretin orexin-A
D03 Hcrtr1 Hypocretin (orexin) receptor 1 Hctr1
D04 Hrh1 Histamine receptor H 1 Hisr
D05 Htr2c 5-hydroxytryptamine (serotonin) receptor 2C 1C 5-HT2C, 5-HTR2C, 5HT-
D06 Iapp Islet amyloid polypeptide –
D07 IL-1α Interleukin 1 alpha IL-1 alpha
D08 IL-1b Interleukin 1 beta –
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Table 1 The symbol and description of genes in the PCR array (Continued)
D09 IL-1r1 Interleukin 1 receptor, type I –
D10 IL-6 Interleukin 6 ILg6, Ifnb2
D11 IL-6r Interleukin 6 receptor IL6R1, Il6ra, Il6r
D12 Ins1 Insulin 1 –
E01 Ins2 Insulin 2 –
E02 Insr Insulin receptor –
E03 Lep Leptin OB, obese
E04 Lepr Leptin receptor Fa
E05 Mc3r Melanocortin 3 receptor MC3-R
E06 Mchr1 Melanin-concentrating hormone receptor 1 Gpr24, Mch-1r, Slc1
E07 Nmb Neuromedin B RGD1562710
E08 Nmbr Neuromedin B receptor NMB-R
E09 Nmu Neuromedin U –
E10 Nmur1 Neuromedin U receptor 1 Gpr66
E11 Npy Neuropeptide Y NPY02, RATNPY, RATNPY02
E12 Npy1r Neuropeptide Y receptor Y1 MGC109393, NPY-1
F01 Nr3c1 Nuclear receptor subfamily 3, group C, member 1 GR, Gcr, Grl
F02 Ntrk1 Neurotrophic tyrosine kinase, receptor, type 1 Trk
F03 Nts Neurotensin –
F04 Ntsr1 Neurotensin receptor 1 Ntsr
F05 Oprk1 Opioid receptor, kappa 1 –
F06 Oprm1 Opioid receptor, mu 1 MORA, Oprm, Oprrm1
F07 Pomc Proopiomelanocortin Pomc1, Pomc2
F08 Ppara Peroxisome proliferator activated receptor alpha PPAR
F09 Pparg Peroxisome proliferator-activated receptor gamma –
F10 Ppargc1a Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha Ppargc1
F11 Prlhr Prolactin Releasing Hormone Receptor Prlhr
F12 Ptpn1 Protein tyrosine phosphatase, non-receptor type 1 MGC93562, Ptp
G01 Pyy Peptide YY (mapped) GHYY, RATGHYY, Yy, peptide-YY
G02 Ramp3 Receptor (G protein-coupled) activity modifying protein 3 –
G03 Sigmar1 Sigma non-opioid intracellular receptor 1 Oprs1
G04 Sort1 Sortilin 1 Nt3, Nts3
G05 Sst Somatostatin SS-14, SS-28, Smst
G06 Sstr1 Somatostatin receptor 1 Gpcrrna
G07 Thrb Thyroid hormone receptor beta C-erba-beta, ERBA2, Nr1a2, RATT3REC,
T3rec, TRbeta
G08 Tnf Tumor necrosis factor (TNF superfamily, member 2) MGC124630, RATTNF, TNF-alpha, Tnfa
G09 Trh Thyrotropin releasing hormone THR, TRH01
G10 Trhr Thyrotropin releasing hormone receptor –
G11 Ucn Urocortin –
G12 Ucp1 Uncoupling protein 1 (mitochondrial, proton carrier) MGC108736, Ucp, Ucpa, Uncp
H01 Actb Actin, beta Actx
H02 B2m beta-2-microglobulin -
H03 Hprt1 Hypoxanthine phosphoribosyltransferase 1 Hgprtase, Hprt, MGC112554
H04 Ldha Lactate dehydrogenase A Ldh1
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Results
Abdominal fats and visceral adiposity index
An increase in retroperitoneal adipose tissue was observed
in CRP but not in HRP compared to their respective non-
treated controls (CS and HCHF groups) (Table 2). On the
other hand, HRP group showed significant increase (p <
0.05) in epididymal and omental fat deposition compared
with CS and HCHF diet-fed rats (Table 2). No changes in
visceral adiposity index were seen for red pitaya supplemen-
tation in high-carbohydrate, high-fat diet-fed rats (Table 2).
On the other hand, CRP rats showed a trend of increasing
visceral adiposity index but the differences were not signifi-
cant (p > 0.05) (Table 2).
Plasma inflammatory markers
Results indicated that red pitaya supplementation signifi-
cantly increased (p < 0.05) plasma concentration of TNF-
α and IL-6 (Table 2). There was no difference for CRP
group for IL-6 concentration in comparison with CS-fed
rats (Table 2). C-reactive protein, an acute phase react-
ant was increased with high-carbohydrate, high-fat feed-
ing compared with corn starch fed control rats (Table 2).
Red pitaya juice supplementation decreased C-reactive
protein concentration in HRP rats as compared to con-
trols rats (Table 2).
Gene expression analysis
Concentration of extracted RNA
Total RNA was successfully extracted from the liver tis-
sues of HCHF, HRP CS, and CRP. For the best results
from the RT2 Profiler PCR Array, all RNA samples should
exhibit consistent quality and purity. High purity of RNA
should have an A260/A280 reading between 1.8 and 2.0 and
an A260/A230 reading should be greater than 1.7. On top
of that, the concentration determined by A260 should be
greater than 40 μg/mL. In the present study, all the sam-
ples fulfill the criteria indicating high purity of RNA.
Gene expressions alterations
The triplicate samples from each group produced repro-
ducible results. Data analysis revealed that 14 genes (as
measured by CT value) were detected while the remaining
71 genes were not detected and/or the genes were de-
tected but the variation between the test sample and con-
trol is too great and thus the fold change results has to be
validated further. Figure 1 shows the fold regulation
Table 1 The symbol and description of genes in the PCR array (Continued)
H05 Rplp1 Ribosomal protein, large, P1 MGC72935
H06 RGDC Rat Genomic DNA Contamination RGDC
H07 RTC Reverse Transcription Control RTC
H08 RTC Reverse Transcription Control RTC
H09 RTC Reverse Transcription Control RTC
H10 PPC Positive PCR Control PPC
H11 PPC Positive PCR Control PPC
H12 PPC Positive PCR Control PPC
(Source: SABioscience, 2014)
Table 2 Visceral adiposity index, abdominal fat, and plasma inflammatory markers in CS, CRP, HCHF and HRP diet-fed rats
Variable CS CRP HCHF HRP P-value
Diet Treatment Interaction
Visceral adiposity index (%) 3.5 ± 0.3bc 4.6 ± 0.5b 6.6 ± 0.6a 7.0 ± 0.5a <0.0001 0.05 0.16
Abdominal fat, mg/mm tibial length
Retroperitoneal (n = 7–8) 118.9 ± 12.9c 181.7 ± 15.2b 303.7 ± 26.6a 357.7 ± 32.6a <0.0001 0.0217 0.0341
Omental (n = 7–8) 102.5 ± 7.3cd 142.4 ± 12.3cd 173.9 ± 44.0bc 260.3 ± 27.6a <0.0001 0.0141 0.27
Epididymal (n = 7–8) 64.4 ± 7.0cd 101.3 ± 11.4bd 112.1 ± 34.6bc 191.0 ± 13.9a <0.0001 0.0012 0.3
Plasma inflammatory markers
IL-6 (pg/mL) (n = 7–8) 3.40 ± 0.48a 3.63 ± 0.27a 1.82 ± 0.19b 3.91 ± 0.56a 0.0004 0.0112 <0.0001
TNF-alpha (pg/mL) (n = 7–8) 1.08 ± 0.34b 1.20 ± 0.16b 1.13 ± 0.20b 1.83 ± 0.39a 0.0448 0.13 0.7465
CRP, mg/L (n = 5–8) 0.26 ± 0.04b 0.21 ± 0.004b 0.34 ± 0.07a 0.13 ± 0.02b 0.006 <0.0001 0.6422
Each value is a mean ± S.E.M. Number of repetitive experiments indicated within parenthesis. Means within a row with unlike superscripts letters a, b, c, d differ
significantly (p < 0.05). CS, corn starch diet; CRP, corn starch + red pitaya juice; HCHF, high-carbohydrate, high-fat diet; HRP, high-carbohydrate, high-fat diet + red
pitaya juice
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expression data for all the genes between CS and HCHF
groups, CS and CRP groups and HCHF and HRP groups.
Table 3 presents the fold regulation of the selected genes
from HCHF, HRP, CS and CRP groups that gave reprodu-
cible results. In HCHF-fed rats, four genes were down-
regulated namely complement component 3 (C3), ciliary
neurotrophic factor receptor (Cntfr), glucagon receptor
(Gcgr) and interleukin 1 alpha (IL-1α) while three genes
were up-regulated which are insulin receptor (Insr), neuro-
peptides Y (Npy) and Sigma non-opioid intracellular recep-
tor 1 (Sigmar1) and four genes namely Apolipoprotein A-
IV (Apoa4), Interleukin 1 receptor, type 1 (IL-1r1), Proopio-
melanocortin (Pomc), and Thyroid hormone receptor beta
(Thrb) showed no changed as compared to CS group
(Table 3). Nevertheless, only the expression level Cntfr, IL-
1α and IL-1r1 were significantly different (p < 0.05) com-
pared to CS group (Fig. 2). Corn starch-fed supplemented
rats (CRP group) significantly decreased (p <0.05) the ex-
pression of Cntfr and IL-1α (Fig. 3). Supplementation of
red pitaya juice for eight weeks resulted in up-regulation of
Insr and Pomc in HRP group compared to HCHF group
(Table 3). However, the difference showed no statistical sig-
nificance (p > 0.05) (Fig. 4).
Discussion
The present study evaluated the red pitaya-targeted
genes in high-carbohydrate, high-fat diet-induced meta-
bolic syndrome rats using polymerase chain reaction
1 2 3 4 5 6 7 8 9 10 11 12
A Adcyap1 Adcyap1r1 Adipoq Adipor1 Adipor2 Adra2b Adrb1 Agrp Apoa4 Atrn Bdnf Brs3
B C3 Calca Calcr Cartpt Cck Cckar Clps Cnr1 Cntf Cntfr Crh Crhr1
C Drd1 Drd2 Gal Galr1 Gcg Gcgr Gh1 Ghr Ghrl Ghsr Glp1r Grp
D Grpr HcRt Hcrtr1 Hrh1 Htr2c Iapp Il1a Il1b Il1r1 Il6 Il6r Ins1
E Ins2 Insr Lep Lepr Mc3r Mchr1 Nmb Nmbr Nmu Nmur1 Npy Npy1r
F Nr3c1 Ntrk1 Nts Ntsr1 Oprk1 Oprm1 Pomc Ppara Pparg Ppargc1a Prlhr Ptpn1
G Pyy Ramp3 Sigmar1 Sort1 Sst Sstr1 Thrb Tnf Trh Trhr Ucn Ucp1
H Actb B2m Hprt1 Ldha Rplp1 RGDC RTC RTC RTC PPC PPC PPC
a.  CS vs. HCHF b.  CS vs .CRP c.  HCHF vs .HRP 
d. PCR array gene table  
Fig. 1 The changes in obesity-related genes among the controls, CRP and HRP groups. The heat map demonstrating fold regulation expression data
between CS group and HCHF group (a), CS group and CRP group (b) and HCHF group and HRP group (c). d shows representative PCR array gene table
Table 3 Fold regulations of detected genes from HCHF, HRP, CS
and CRP groups
Gene Fold regulation
CS vs. HCHF CS vs. CRP HCHF vs. HRP
Adipor1 ND 1.32 1.67
Apoa4 −1.13 −13.15 1.89
C3 −2.47 −1.19 1.43
Cnr1 ND 1.92 ND
Cntfr −2.79* −2.82* ND
Gcgr −5.17 −1.31 1.74
Ghr ND −2.85 ND
IL-1α −5.55* −3.60* ND
IL-1r1 1.53* 1.02 1.67
Insr 2.01 1.37 2.09
Npy 2.79 ND 1.54
Pomc 1.24 −1.20 2.09
Sigmar1 2.43 1.55 1.62
Thrb 1.95 −1.16 1.62
CS, corn starch diet; CRP, corn starch + red pitaya juice; HCHF, high-
carbohydrate, high-fat diet; HRP, high-carbohydrate, high-fat diet + red
pitaya juice
*indicate significant difference at p < 0.05
ND; non-detected genes
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(PCR) array in order to elucidate the molecular mechan-
ism underlying the physiological responses. PCR array
combines real-time PCR sensitivity and the ability of mi-
croarrays to detect the expression of many genes simul-
taneously [13]. This new technique of evaluating gene
expression allows the expression levels of disease- or
pathway-focused genes and provides reliable method,
easy-to-use and is highly sensitive [14]. Up to now,
quantitative RT-PCR arrays have had limited use to
study nutrient-related interventions [15], maternal peri-
natal under-nutrition [16, 17] and brown adipose tissue
metabolism [18], probably because of high cost despite
the improved sensitivity.
Analysis from the present study revealed that several
obesity-related genes change in HCHF groups, which
further confirmed the development of this metabolic
syndrome rat model. In obese rats, four genes were
down-regulated (C3, Cntfr, Gcgr, IL-1α) while three
genes were up-regulated (Insr, Npy and Sigmar1) and
five genes (Adipor1, Apoa4, IL-r1, Pomc, Thrb) showed
no change compared to CS group. However, among
these, only Cntfr, IL-1α and IL-1r1 showed significant
changes which might be due to large variations of the
expression levels of other genes within the groups. IL-1α
and IL-1r1 are classified as anorectic genes. The appetite
suppressing effects of these two genes (IL-1α and IL-
1r1) might be associated with fever, increased thermo-
genesis and reduced food intake due to inflammation
and injury [19]. Interleukin-1α is cytokine of the
interleukin-1 family (IL-1) which is a key mediator of in-
flammation, located on the long arm of human chromo-
some 2 [20]. IL-1 family also composed of IL-1β that
exerts almost identical biological activities with IL-1α by
binding to IL-1 type 1 receptor (IL-1r1). However, IL-1β
does not occur in healthy subjects. In contrast, IL-1α is
present at constitutive levels in primary cells such as he-
patocytes and epithelial cells [21]. IL-1α forms heterodi-
meric complexes that induce inflammation when bound
to the IL-1r1. The negative regulator of inflammation is
IL-1 receptor antagonist (IL-1Ra) [18].
García et al. [19] showed that knockout of the gene cod-
ing for IL-1r1 resulted in mature-onset obesity due to re-
duced fat utilization, decreased locomotor activity and
reduced leptin sensitivity. Data from our previous study
indicated that body weight of HCHF-fed rats were signifi-
cantly higher than CS-fed rats [10] despite the same ex-
pression level of IL-1r1. Possibly, other genes play role in
increasing body weight of H-fed rats but not IL-1r1. Fur-
thermore, serum amyloid A protein, an inflammatory
marker in atherosclerosis, was reduced despite higher total
cholesterol concentrations in IL-1α deficient mice fed with
high-fat diet [22]. Similarly, the present study showed the
expression level of IL-1α was significantly reduced in line
with the decreased inflammatory markers of interleukin-6
in HCHF-fed rats compared to CS group. The relationship
between inflammation and obesity is well established
[23, 24, 25]. It is interesting to point out that the contra-
dictory results obtained from the present study might be
due to increased inflammation in control rats without
high-fat diet probably due to enhance glucose intake after
meal as reported by Gregerson et al. [26]. Importantly,
these results explained the condition whereby the appetite
suppressing effect of IL-1α was altered resulting in in-
creased food intake, and hence increased body weight of
H-fed rats. Recently, Dinarello and Netea [27] postulated
that IL-1α deficient mice had reduced aortic lesion size
due to the transferred of hematopoietic cells from the
bone marrow. However, the aortic lesion was not mea-
sured in the present study, so the effect of IL-1α down-

























Fig. 2 The changes of obesity-related genes from HCHF and CS
groups. a The volcano plot demonstrating statistical significance versus
fold regulation expression data between the HCHF group and the CS
group. The blue line indicates p-value, set at 0.05. b Genes with significant
differences (p < 0.05) between the two groups are presented in
the histogram. CS, corn starch diet; HCHF, high-carbohydrate, high-fat
diet; Cntfr, ciliary neurotrophic factor receptor; IL-1 α, Interleukin 1
alpha; IL-1r1, Interleukin 1 receptor, type I
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Cntfr, Gcgr and Insr are anorectic genes, Sigmar1 and
Npy are orexigenic genes and C3 is the gene that relate
to energy expenditure. Although there were no statisti-
cally significant for these genes between the HCHF
group and CS group except for Cntfr, it is important to
understand the changes of obesity-related genes as a first
critical step towards evaluating this metabolic syndrome
rat model at the molecular level. The role of C3 in
obesity-related metabolic diseases has been recognized
as it stimulates the accumulation of triglyceride, pro-
motes the uptake of glucose and reduces the release of
free fatty acids [28]. Besides, the up-regulation of C3 im-
paired energy expenditure and food intake via its action
on the central nervous system [29]. It is fascinating that
the C3 expression decreases with obesity in the present
study given that C3 mRNA expression levels typically
positively correlated with obesity. Nevertheless, this find-
ing is in agreement with recent discovery by Gupta et al.
[30] whereby they found down-regulation of comple-
ment C3 in subcutaneous tissue of obese women.
Cntfr reduces food intake and increase energy expend-



























Fig. 3 The changes of obesity-related genes from CS and CRP groups. a The volcano plot demonstrating statistical significance versus fold regulation
expression data between the CS group and the CRP group. The blue line indicates p-value, set at 0.05. b Genes with significant differences (p < 0.05)
between the two groups are presented in the histogram. CS, corn starch diet; CRP, corn starch + red pitaya juice; Cntfr, ciliary neurotrophic factor
receptor; IL-1 α, Interleukin 1 alpha
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[31, 32]. Therefore, the absence of this protective factor
against high-carbohydrate, high-fat diet resulted in weight
gain and obesity. Gcgr is a receptor for glucagon which
mediated the process of glycogenolysis, lipolysis, ketogen-
esis and gluconeogenesis. Following carbohydrate-rich
meal, the expression level of Gcgr is significantly de-
creased [5], which is in agreement with the present study.
Furthermore, the increased in Npy and Sigmar1 gene ex-
pression further supported this obesity rat model. Npy is
part of the hypothalamic melanocortin pathway that regu-
lates the central energy metabolism [33]. Previous study
has demonstrated the increased in Npy expression stimu-
lated food intake and hence resulted in weight gain [34].
Similarly, obese individual with non-alcoholic fatty liver
diseases was found to have up-regulation of opioid signal-
ling including Sigmar1 [35]. On the other hand, the
expression level of Insr was up-regulated. Insr, the hetero-
dimer genes coding for insulin signalling members, have
been reported to be significantly reduced in obesity [36].
Thus, the up-regulation of Insr in the present study may
lead to feedback down-regulation to reduce food intake
due to increasing body weight of H-fed rats. The exact
mechanism, however, is unknown.
There was report that bioactive compounds and nutri-
ents in food can interact with the genome by highly
complex forms [37]. For instance, administration of oleic
acid through intracerebroventricular was found to de-
crease body weight by reduction of Npy and increase
Pomc neuron [38]. Additionally, Lu et al. [15] found that
supplementation of green tea polyphenols in high-fat in-
duced obese rats reduced body weight through mediating
obesity-related genes. In the present study, the expression
of Insr and Pomc increased in obese rats supplemented
with red pitaya while no changes were observed in seven
genes (Adipor1, Apoa4, C3, Gcgr, IL-1r1, Insr, Npy, Pomc,
Sigmar1 and Thrb). There was no statistical significance
between the HRP group and H group that warrant future
research with bigger sample size. Insulin plays critical
roles in energy functions particularly in carbohydrate and
lipid metabolism. Obese individual usually has marked de-
clined in insulin levels [5]. Thus, the increased gene ex-
pression level of Insr in HRP group indicating that red
pitaya ameliorates the deficiency or resistant of insulin in
obese rats. Meanwhile, Pomc is important for central
regulation of energy balance whereby it reduce food intake
and increase energy expenditure via the release of α
melanocyte-stimulating hormone (MSH) and activation of
melanocortin receptors [39].
In addition, CRP group revealed the decreased expres-






Fig. 4 The changes of obesity-related genes from HCHF and HRP groups. a The volcano plot demonstrating statistical significance versus fold
regulation expression data between the HCHF group and the HRP group. The blue line indicates p-value, set at 0.05. None of the genes for this
group is significantly different at p < 0.05. HCHF, high-carbohydrate, high-fat diet; HRP, high-carbohydrate, high-fat diet + red pitaya juice
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Among these, only IL-1α and Cntfr provides a significant
reduction. As mentioned before, the increase expression
of IL-1α and Cntfr induce satiety which in turn reduce the
food intake and promote weight loss. Ghr plays a critical
role in lipolysis, adipogenesis and lipogenesis and lower
Ghr expression in the adipocyte is associated with obesity
[40]. Likewise, Apoa4 triggered the satiety signal through
dietary fat [41] and the decreased gene expression level of
Apoa4 contributed to weight gain [15]. These findings
confirmed that the lean control rats in the present study
were more sensitive to the palatability of red pitaya juice
as compared to high-carbohydrate, high-fat diet-induced
obese rats. Red pitaya juice is an example of palatable
foods that inhibit the satiety signals and hence increasing
the food intake of CRP rats. Red pitaya juice contains
higher amount of energy-supplying macronutrients caus-
ing progressive increment in body weight, and total body
fat throughout the intervention period. This could ex-
plained the increased in abdominal fat deposition in CRP
rats in the absence of a high carbohydrate, high fat diet.
As discussed earlier, the analysis on the obesity-related
genes after supplementation with red pitaya juice re-
sulted in the detection of 14 genes. The remaining 70
genes were not detected in the liver samples of all the
three groups. The likely reasons for this condition are
those undetected genes were weakly expressed or not
expressed at all in the liver tissues. For instance, Calcr is
typically expressed in the kidney and brain, Cartpt is
normally expressed in the spinal cord, testis, prostate
and brain while Brs3 is normally detected in the testis,
kidney and brain [42]. Moreover, Lu et al. [15] suggested
that the gene array may have limitation in the sensitivity
of the detection. The authors also proposed that the
changes in gene expression might not be detected in the
mixture of cell types in tissue samples.
Interestingly, data showed that supplementation of red
pitaya juice decreased the circulating C-reactive protein
(CRP), thus reducing the diet-induced low grade inflam-
mation in-vivo. A possible explanation for this might be
that red pitaya supplementation reduced CRP concentra-
tion by reducing its production rate without altering the
liver genes. Mauger et al. [43] reported that the main de-
terminant for CRP concentration is its production rate
which showed significant association with metabolic syn-
drome characteristics. In contrast, a recent study on the
mechanism of CRP reduction by statins, a drug used for
the treatment of hypercholesterolemia, indicated that its
production was not reduced but the fractional catabolic
rate was enhanced [44]. It is speculated that the in-
creased in pro-inflammatory cytokines (IL-6 and TNF-
alpha) was due to increase in liver fat as supplementa-
tion of red pitaya added to total energy content in high
carbohydrate, high fat diet. Although the secretion of IL-
6 regulates the induction of CRP in hepatocytes [45], the
present study found contradicts results. As red pitaya
supplementation increased IL-6, plasma concentration
of CRP was reduced. In agreement with the present
study, Malavazos et al. [46] found no positive association
between IL-6 and CRP. In fact, a recent study reported
that the intake of statin lowered CRP concentration but
the study found no association between statin use and
other inflammatory cytokines especially IL-6, TNF-α,
and IL-1β [47].
Conclusions
In summary, the present results demonstrated that genetic
mechanisms play a major role in determining body weight
by controlling energy balance homeostasis. The present
study provides striking results in that the changes in anor-
ectic, orexigenic and energy expenditure related genes not
only to advance the understanding of beneficial effects of
red pitaya, but the usefulness of this diet-induced rat
model. However, the overall effects of red pitaya supple-
mentation are still controversial as inconsistent results
were obtained. Longer duration of study may be required.
Furthermore, it is important to highlight the complexity
of energy balance homeostasis that may be time-specific,
and/or tissue- and species specific [48]. Nevertheless, the
changes in anorectic, orexigenic and energy expenditure
related genes observed in the present study provide the sa-
lient and novel findings for obesity research. This work
can be further extended to investigate possible therapeutic
effects of red pitaya supplementation on metabolic syn-
drome patient which will in turn help to fight against the
obesity epidemic.
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